BeaconDx Information

Company Overview BeaconDx is pioneering a breakthrough diagnostic platform using a unique diagnostic fluid, MENSA (Media Enriched with Newly Synthesized Antibodies), enabling measurement of ongoing immune response. Unlike standard serologic testing, MENSA gives a dynamic snapshot of potential ongoing viral activity by detecting newly synthesized antibodies, offering first-in-class data for possible persistent and reactivated infections in affected patients. Unmet Need Complex chronic disease afflicts ~9% of the US population after an acute infection, causing extreme, sometimes debilitating, symptoms for months to years BeaconDx's immune snapshot platform overcomes this by enabling the measurement of real-time immune responses, potentially elicited by ongoing or reactivated infections, even in the presence of high levels of circulating antibodies from prior infections